These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23274843)

  • 1. Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms.
    Borgquist S; Hjertberg M; Henningson M; Ingvar C; Rose C; Jernström H
    Breast Cancer Res Treat; 2013 Feb; 137(3):849-62. PubMed ID: 23274843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women.
    Paulus JK; Zhou W; Kraft P; Johnson BE; Lin X; Christiani DC
    Lung Cancer; 2011 Mar; 71(3):258-63. PubMed ID: 20655613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
    Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
    Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
    Vinayagam R; Sibson DR; Holcombe C; Aachi V; Davies MP
    BMC Cancer; 2007 Jul; 7():131. PubMed ID: 17640362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta gene polymorphism and intraocular pressure elevation in female patients with primary open-angle glaucoma.
    Mabuchi F; Sakurada Y; Kashiwagi K; Yamagata Z; Iijima H; Tsukahara S
    Am J Ophthalmol; 2010 May; 149(5):826-30.e1-2. PubMed ID: 20399928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.
    Yu KD; Rao NY; Chen AX; Fan L; Yang C; Shao ZM
    Breast Cancer Res Treat; 2011 Feb; 126(1):37-45. PubMed ID: 20390341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.
    Hietala M; Henningson M; Törngren T; Olsson H; Jernström H
    Mol Genet Metab; 2011 Jan; 102(1):82-90. PubMed ID: 20947401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
    Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort.
    Markkula A; Bromée A; Henningson M; Hietala M; Ringberg A; Ingvar C; Rose C; Jernström H
    Cancer Causes Control; 2012 Aug; 23(8):1307-16. PubMed ID: 22695757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
    Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.